Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.
2.
4.
5.
6.

Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).

Murphy DL, Karoum F, Pickar D, Cohen RM, Lipper S, Mellow AM, Tariot PN, Sunderland T.

J Neural Transm Suppl. 1998;52:39-48.

PMID:
9564606
7.

Increased stress response and beta-phenylethylamine in MAOB-deficient mice.

Grimsby J, Toth M, Chen K, Kumazawa T, Klaidman L, Adams JD, Karoum F, Gal J, Shih JC.

Nat Genet. 1997 Oct;17(2):206-10.

PMID:
9326944
8.

Cerebrospinal fluid monoamine metabolites in childhood-onset schizophrenia.

Jacobsen LK, Frazier JA, Malhotra AK, Karoum F, McKenna K, Gordon CT, Hamburger SD, Lenane MC, Pickar D, Potter WZ, Rapoport JL.

Am J Psychiatry. 1997 Jan;154(1):69-74.

PMID:
8988961
9.
10.

Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.

Lenders JW, Eisenhofer G, Abeling NG, Berger W, Murphy DL, Konings CH, Wagemakers LM, Kopin IJ, Karoum F, van Gennip AH, Brunner HG.

J Clin Invest. 1996 Feb 15;97(4):1010-9.

11.

Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.

Egan MF, Chrapusta S, Karoum F, Lipska BK, Wyatt RJ.

J Neural Transm (Vienna). 1996;103(7):777-805. Review.

PMID:
8872864
12.

Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia.

Wyatt RJ, Karoum F, Casanova MF.

Biol Psychiatry. 1995 Jul 1;38(1):4-12.

PMID:
7548471
13.

Questions about the dopamine terminals in human frontal cortex.

Hitri A, Karoum F, Wyatt RJ.

J Neurochem. 1995 Apr;64(4):1901-3. No abstract available.

PMID:
7891122
14.
16.
17.
18.
19.

Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine release.

Chrapusta SJ, Karoum F, Egan MF, Wyatt RJ.

Eur J Pharmacol. 1993 Mar 16;233(1):135-42.

PMID:
8472742
20.
21.
22.

Marked reduction in indexes of dopamine metabolism among patients with depression who attempt suicide.

Roy A, Karoum F, Pollack S.

Arch Gen Psychiatry. 1992 Jun;49(6):447-50.

PMID:
1376107
24.

Regulatory aspects of nigrostriatal dopaminergic neurons.

Miu P, Karoum F, Toffano G, Commissiong JW.

Exp Brain Res. 1992;91(3):489-95.

PMID:
1483521
25.

Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes.

Collins FA, Murphy DL, Reiss AL, Sims KB, Lewis JG, Freund L, Karoum F, Zhu D, Maumenee IH, Antonarakis SE.

Am J Med Genet. 1992 Jan 1;42(1):127-34.

PMID:
1308352
26.

Dorsal hippocampal lesion does not affect dopaminergic indices in the basal ganglia.

Lipska BK, Jaskiw GE, Karoum F, Phillips I, Kleinman JE, Weinberger DR.

Pharmacol Biochem Behav. 1991 Sep;40(1):181-4.

PMID:
1664108
27.

Recovery of function in spinalized, neonatal rats.

Commissiong JW, Sauve Y, Csonka K, Karoum F, Toffano G.

Brain Res Bull. 1991 Jul;27(1):1-4.

PMID:
1933420
29.

Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex.

Wahlestedt C, Karoum F, Jaskiw G, Wyatt RJ, Larhammar D, Ekman R, Reis DJ.

Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2078-82.

30.

Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.

Murphy DL, Sims KB, Karoum F, Garrick NA, de la Chapelle A, Sankila EM, Norio R, Breakefield XO.

J Neural Transm Gen Sect. 1991;83(1-2):1-12.

PMID:
2018626
32.

Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat.

Jaskiw GE, Karoum F, Freed WJ, Phillips I, Kleinman JE, Weinberger DR.

Brain Res. 1990 Nov 26;534(1-2):263-72.

PMID:
2073588
33.
34.
35.

Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.

Murphy DL, Sims KB, Karoum F, de la Chapelle A, Norio R, Sankila EM, Breakefield XO.

J Neurochem. 1990 Jan;54(1):242-7.

PMID:
2293615
36.

Suicidal behavior in depression: relationship to noradrenergic function.

Roy A, Pickar D, De Jong J, Karoum F, Linnoila M.

Biol Psychiatry. 1989 Feb 1;25(3):341-50.

PMID:
2914156
37.
38.

Persistently decreased brain dopamine levels and cocaine.

Wyatt RJ, Karoum F, Suddath R, Fawcett R.

JAMA. 1988 May 27;259(20):2996. No abstract available.

PMID:
3367471
39.
40.

D-dopa and L-dopa similarly elevate brain dopamine and produce turning behavior in rats.

Karoum F, Freed WJ, Chuang LW, Cannon-Spoor E, Wyatt RJ, Costa E.

Brain Res. 1988 Feb 2;440(1):190-4.

PMID:
3129126
41.
42.

High intercorrelations among urinary outputs of norepinephrine and its major metabolites. A replication in depressed patients and controls.

Roy A, Guthrie S, Karoum F, Pickar D, Linnoila M.

Arch Gen Psychiatry. 1988 Feb;45(2):158-61.

PMID:
3337613
43.

Thyrotropin releasing hormone test in unipolar depressed patients and controls: relationship to clinical and biologic variables.

Roy A, Karoum F, Linnoila M, Pickar D.

Acta Psychiatr Scand. 1988 Feb;77(2):151-9.

PMID:
3129906
44.
45.

Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia.

Karoum F, Karson CN, Bigelow LB, Lawson WB, Wyatt RJ.

Arch Gen Psychiatry. 1987 Jul;44(7):604-7. Erratum in: Arch Gen Psychiatry 1987 Oct;44(1)):861.

PMID:
2440412
46.

Treatment of hyperactive children with D-phenylalanine.

Zametkin AJ, Karoum F, Rapoport JL.

Am J Psychiatry. 1987 Jun;144(6):792-4.

PMID:
3296793
47.

Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients.

Szymanski HV, Naylor EW, Karoum F.

Biol Psychiatry. 1987 Feb;22(2):194-8.

PMID:
3814669
48.

Central catecholamines, cognitive impairment, and affective state in elderly schizophrenics and controls.

Bridge TP, Kleinman JE, Soldo BJ, Karoum F.

Biol Psychiatry. 1987 Feb;22(2):139-47.

PMID:
3814666
50.

Urinary monoamines and monoamine metabolites in subtypes of unipolar depressive disorder and normal controls.

Roy A, Pickar D, Douillet P, Karoum F, Linnoila M.

Psychol Med. 1986 Aug;16(3):541-6.

PMID:
3763772

Supplemental Content

Loading ...
Support Center